TORAKS 2022

Program liječnici

 Srijeda 24. svibnja 2023 | Wednesday, May 24th 2023
14:00-19:15Registracija sudionika | Registration
 ZELENA PLUĆA | GREEN LUNGS
 Voditelji /Chairpersons: Mirna Vergles, Željko Čulina, Radovan Zrilić, Josipa Meter
15:00-15:20

Marija Gomerčić- Palčić

Onečišćenje zraka i bolesti pluća
Air pollution and respiratory diseases 

15:20-15:40

Jelena Ostojić

Zdravstveni rizici elektronskih cigareta
Health risks of electronic cigarettes

15:40-16:00

Žarko Vrbica

Mikroplastika u zraku i plućima
Microplastics in the air and lungs

16:00-16:20

Andrea Vukić Dugac, Žarko Vrbica

Virtualni digitalni pomoćnici u respiratornoj medicini
Virtual digital assistants in respiratory medicine

16:20-16:30

Ana Hećimović

Plućna hipertenzija- nove dijagnostičke i terapijske smjernice
Pulmonary hypertension – new diagnostic and treatment guidelines

16:30-17:00Simpozij – Sponzoriran
Symposium Sponsored by MSD
 

Feđa Džubur

Koje nam promjene donose nove ERS-ESC smjernice u dijagnostici i liječenju bolesnika s plućnom hipertenzijom?
What changes bring us the new ERS-ESC guidelines in the diagnosis and treatment of patients with pulmonary hypertension?

17:00-17:20Simpozij – Sponzoriran
Symposium Sponsored by Berlin Chemie Menarini Hrvatska
 

Žarko Vrbica

Edoxaban – dokazi iz stvarnog svijeta – ETNA-AF, praćenje kroz 2 godine
Edoxaban-real world evidence-ETNA-AF, 2 year follow-up

 

Respiratorne infekcije: Tuberkuloza pluća u 21. stoljeću – 141 godina od otkrića R. Kocha

Tuberculosis in the 21st century – 141 years from R. Koch’s discovery

 Voditelji | Chairpersons: Zagorka Boras, Denis Baričević, Dražen Strelec, Vilim Kolarić
17:20-17:40

Denis Baričević

Tuberkuloza pluća – jučer, danas i sutra
Tuberculosis: yesterday, today, tomorrow

17:40-18:00

Mateja Janković Makek

Novosti u liječenju tuberkuloze
New treatment for tuberculosis

18:00-18:20Vesna TrkešTuberkuloza pluća i onečišćenje zraka
Tuberculosis and air pollution
18:20-19:10RANO OTKRIVANJE PLUĆNIH BOLESTI
EARLY DETECTION OF LUNG DISEASES 
 Voditelj | Chairpersons: Miroslav Samaržija, Mario Ravić, Mario Šekerija, Marinko Artuković
 

Melita Kukuljan

Prednosti i nedostaci LDCT u NPP – iskustvo KBC Rijeka
Advantages and disadvantages of LDCT in NLCSP – Single institution experience University hospital Rijeka

 

Kristina Krpina

Rana dijagnostika KOPB – a i rezultati – ekstenzija NPP
Early diagnosis of COPD throught NLCSP – extended version

19:10-19:30

Josip Pejić

Pectus excavatum- minimalno invazivna procedura – iskustvo KB Dubrava
Pectus excavatum – Minimal invasive procedure – experience at Clinical Hospital Dubrava

 Voditelj | Chairperson: Miroslav Samaržija
19:30-19:50Najbolji radovi mladih pulmologa
Best achievements of young pulmonologists
19:50-20:00Dodjela nagrade za izniman doprinos pulmologiji
Award for extraordinary contribution to respiratory medicine
20:00Otvaranje kongresa
Opening ceremony
 Četvrtak 25. svibnja 2023 | Thursday, May 25th 2023
08:30-17:00Registracija sudionika | Registration
 Voditelji | Chairpersons: Maja Hrabak Paar, Nevenka Piskač Živković, Suzana Kukulj, Jasna Tekavec Trkanjec
09:00-09:15

Đivo Ljubičić

Bronhoskopske metode u ne-malignim indikacijama
Bronchoscopy methods in non-malignant indications

09:15-09:30

Ana Marija Alduk

Intervencijska radiologija u pulmologiji
Interventional radiology in pulmonology

09:30-09:45

Sonja Badovinac

Budućnost bronhoskopije u dijagnostici perifernih plućnih lezija
The future of bronchoscopy in peripheral lung lesions diagnostics

09:45-10:00

Ivica Mažuranić

Suvremena CT dijagnostika torakalne regije
Contemporary CT diagnostics of thoracic region

10:00-10:15

Melita Kukuljan

CT-vođena transtorakalna iglene biopsija pleuralnih lezija manjih od 10 mm
CT-guided transthoracic core needle biopsies of focal pleural lesions smaller than 10 mm

10:15-10:20Rasprava | Discussion
10:20-10:50Simpozij – Sponzoriran
Symposium Sponsored by Boehringer-Ingelheim
 

Voditelj | Chairperson: Miroslav Samaržija

Rani probir intersticijske bolesti pluća u bolesnika sa sustavnim bolestima vezivnog tkiva
Early Screening of Interstitial Lung Disease in Patients with Systemic Connective Tissue Diseases

Mislav Radić

Konsenzus o probiru intersticijske bolesti pluća u bolesnika sa sustavnim bolestima vezivnog tkiva
Consensus on the Screening of Interstitial Lung Disease in Patients with Systemic Connective Tissue Diseases

Ana Hećimović

Važnost i mjesto pulmologa u praćenju bolesnika sa sustavnim bolestima
The Importance and Role of Pulmonologists in the Follow-Up of Patients with Systemic Diseases

10:50-11:10

Ivan Škopljanac

Diferencijalna dijagnoza plućnih granulomatoza
Differential diagnosis of lung granulomatosis

11:10-11:30

Ana Hećimović

Dijagnostički i terapijski izazovi u sarkoidozi
Diagnostic and management challenges in sarcoidosis

11:30-11:50Pauza za kavu | Coffee break
 Voditelji | Chairpersons: Ljiljana Bulat Kardum, Ozren Koluder, Sanda Škrinjarić Cincar, Jelena Ostojić
11:50-12:35Simpozij – Sponzoriran
Symposium Sponsored by Swixx Biopharma
 

Sanja Popović Grle, Irena Ivković-Jureković, Branko Pevec

Alergenska imunoterapija i astma
Allergen Immunotherapy and Asthma

12:35-12:55Simpozij – Sponzoriran
Symposium Sponsored by Berlin Chemie Menarini Hrvatska
 

Marija Gomerčić Palčić

Utjecaj alergija na tijek KOPB-a
The influence of allergies on the course of COPD

12:55-13:55Ručak | Lunch
13:55-14:15Simpozij – Sponzoriran
Symposium Sponsored by Berlin Chemie Menarini Hrvatska
 

Andrea Vukić Dugac

Doziranje bronhodilatatorne terapije – ključno za ublažavanje simptoma KOPB-a
Dosing of bronchodilator therapy – key to alleviating COPD symptoms

14:15-15:00Simpozij – Sponzoriran
Symposium Sponsored by Providens
 

The last brick in the wall

Uvodničar | Introducer: Miroslav Samaržija

Voditelj | Chairperson: Sanja Popović Grle

Članovi okruglog stola | Members of the round table: Marija Gomerčić Palčić i Suzana Mladinov

15:00-15:40Simpozij – Sponzoriran
Symposium Sponsored by Berlin Chemie Menarini Hrvatska
 

Mirna Vergles

Što znamo o eozinofilima u astmi?
What do we know about eosinophils in asthma?

Vuk Prica

Benefiti liječenja KOPBa trojnom fiksnom kombinacijom
Benefits of treating COPD with a triple fixed combination

15;40-16:40Simpozij – Sponzoriran
Symposium Sponsored by AstraZeneca
 

Andrea Vukić Dugac, Nikola Bulj, Marko Skelin

“Važnost prvog susjeda”
The Importance of the First Neighbor

Mirna Vergles

TEZSPIRE: nova era u liječenju teške astme
TEZSPIRE: The Next Era in Severe Asthma Management

 Voditelji | Chairpersons: Suzana Mladinov, Fedža Džubur, Đivo Ljubičić, Danijel Sekula
16:40-17:55RESPIRATORNA INSUFICIJENCIJA | RESPIRATORY FAILURE
16:40-16:55

Suzana Mladinov

Portabilna terapija kisikom u opterećenju
Portable oxygen therapy in physical activity

16:55-17:10

Gordana Pavliša

Perkutana kapnografija
Percutaneous capnography

17:10-17:25

Joško Šemnički

Odvajanje od invazivne mehaničke ventilacije
Weaning from invasive mechanical ventilation

17:25-17:40

Igor Barković

Fiziološki učinci ronjenja na dah
Physiological responses during deep breath-hold diving

17:40-17:55

Hrvoje Puretić

OSA u hipoventilacijskom sindromu u pretilih: CPAP ili BPAP?
OSA in Obesity hypoventilation syndrome: CPAP or BPAP?

17:55-18:25Simpozij – Sponzoriran
Symposium Sponsored by Medison Pharma
 

Andrea Vukić Dugac

Novo poglavlje u životu oboljelih od cistične fibroze – naša iskustva
The new chapter in life of cystic fibrosis patients – Croatian experiences

 Petak 26. svibnja 2023 | Friday, May 26th 2023
08:30-17:00Registracija sudionika | Registration
 Voditelji | Chairpersons: Dražena Srdić, Kristina Krpina, Silvana Smojver Ježek, Luka Vrbanić
09:00-09:45Simpozij – Sponzoriran
Symposium Sponsored by BMS
 

Voditelj | Chairperson: Miroslav Samaržija

Novosti u prvoj liniji imunoonkološkog (IO) liječenja raka pluća nemalih stanica
Sharing new data in immunooncology (IO) treatment of first-line NSCLC

Marko Jakopović

Pregled terapijskih opcija 1.linije raka pluća nemalih stanica temeljenih na IO liječenju, mogućnosti i ograničenja uspoređivanja različitih kliničkih ispitivanja
Overview of possible first-line IO-based NSCLC treatments, the possibilities and limitations of cross-trial comparisons

Sanja Pleština

Dugoročna usporedivost djelotvornosti i sigurnosti nivolumaba i ipilimumaba u odnosu na druge terapije 1.linije za uznapredovali rak pluća nemalih stanica: Sustavni pregled literature i mrežna meta-analiza
Long-term comparative efficacy and safety of nivolumab plus pilimumab relative to other first-line therapies for advanced NSCLC: A systematic literature review and network meta-analysis

Miroslav Samaržija

Gdje je mjesto dvojne IO kombinacije u odnosu na druge terapije 1.linije liječenja raka pluća nemalih stanica?
Where is the place for the dual IO combination among the 1L NSCLC treatments?

09:45-10:05

Luka Novosel

Lokalna ablativna terapija osim SBRT
Local Ablative treatment beyond SBRT

10:05-10:25

Izidor Kern

Uloga NGS u dijagnostici raka pluća
The role of NGS in diagnosis of lung cancer

10:25-10:45

Igor Štagljar

Razvoj lijekova za KRAS uz pomoć Umjetne Inteligencije
Drugging KRAS with help of Artificial Intelligence

10:45-11:00Pauza za kavu | Coffee break
11:00-11:45Simpozij – Sponzoriran
Symposium Sponsored by Amgen
 

Trenutno liječenje NSCLC s G12C mutacijom i njegova perspektiva
Current Practice and Perspective in the Treatment of KRAS-mutated NSCLC

Voditelj | Chairperson: Miroslav Samaržija

Sanja Pleština

Današnje prvolinijsko liječenje za KRAS-mutirani uznapredovali NSCLC
Current Frontline Treatment for KRAS-mutated Advanced NSCLC

Marko Jakopović

Drugolinijsko liječenje NSCLC: sadašnji status KRAS-inhibitora
Second Line Treatment of NSCLC: Current Status of KRAS-inhibitors

Snježana Tomić

Kako trenutno testiramo i kako još možemo unaprijediti testiranje na KRAS G12C u NSCLC
How Do We Currently Test and How We Can Further Improve Testing of KRAS G12C In NSCLC

Panel rasprava o trenutnoj praksi i perspektivi liječenja raka pluća s KRAS G12C mutacijom
Panel on Current Practice and Perspective in the Treatment of KRAS G12C Mutated Lung Cancer

Sudionici panela | Panelists: Miroslav Samaržija, Sanja Pleština, Marko Jakopović i Snježana Tomić

11:45-12:45Simpozij – Sponzoriran
Symposium Sponsored by MSD
 Što smo naučili u 5 godina iskustva s Keytrudom?
What have we learned in 5 years of experience with Keytruda?Panelisti | Panelist: Miroslav Samaržija, Marko Jakopović, Lela Bitar
12:45-13:15Simpozij – Sponzoriran
Symposium Sponsored by Johnson & Johnson S.E.
 

Novosti u liječenju NSCLC s EGFR egzon 20ins mutacijom – ciljana terapija
Expanding horizons for the targeted management of EGFR exon 20ins NSCLCMiroslav Samaržija

NSCLC s EGFR egzon 20ins mutacijom
NSCLC with EGFR exon 20ins mutation

Marko Jakopović

CHRYSALIS ispitivanje, grana D i prvo iskustvo liječenja amivantamabom
CHRYSALIS cohort D study and first amivantamab patient experience

13:15-13:45Simpozij – Sponzoriran
Symposium Sponsored by Pfizer
 

Lorviqua – brain protector

Miroslav Samaržija

Neispunjene medicinske potrebe kod ALK+ mNSCLC
Unmet medical needs in ALK+ mNSCLC

Aleksandra Roglić

Breme metastaza u SŽS-u
Burden of metastases in CNS

Sanja Pleština

Ažurirani rezultati CROWN ispitivanja nakon 3 godine praćenja
Updated results of the CROWN trial after 3 years of follow-up

13:45-14:45Ručak | Lunch
 Voditelji | Chairpersons: Marta Koršić, Vide Popović, Sanja Pleština, Željko Kupanovac
14:45-15:15Simpozij – Sponzoriran
Symposium Sponsored by Roche
 

Voditelj | Chairperson: Miroslav Samaržija

Od Alecense do precizne terapije
From Alecensa to precision therapy

Sanja Pleština, Marijo Boban

15:15-15:45Simpozij – Sponzoriran
Symposium Sponsored by AstraZeneca
 

Nove mogućnosti liječenja resektabilnog EGFRm NSCLC-a
New possibilities in the treatment of resectable EGFRm NSCLC

Marko Jakopović, Goran Madžarac, Ana Marija Alduk, Vide Popović

15:45-16:30Simpozij – Sponzoriran
Symposium Sponsored by Roche
 

Voditelj | Chairperson: Marko Jakopović

IMpower – snaga dokaza u liječenju raka pluća kroz stadije
IMpower – the power of evidence in the treatment of lung cancer across the stages

Dražena Srdić, Ivana Canjko, Lela Bitar

16:30-16:50Simpozij – Sponzoriran
Symposium Sponsored by TAKEDA
 

Miroslav Samaržija

Dijagnostički i terapijski izazovi u bolesnika s ALK+ rakom pluća
Diagnostic and therapeutic challenges in ALK+ lung cancer

Marko Jakopović

Terapijske odluke, klinička djelotvornost i tolerabilnost liječenja bolesnika s ALK+ rakom pluća
Therapeutic decisions, clinical effectiveness, and treatment tolerability in patients with ALK+ lung cancer

16:50-17:35Simpozij – Sponzoriran
Symposium Sponsored by Pfizer
 

Neven Papić

Mogućnosti i ograničenja cjepiva protiv COVID-19. Tko, kada i zašto bi se trebao cijepiti?
Possibilities and limitations of the vaccine against COVID-19. Who, when and why should be vaccinated?

Gordana Pavliša

Paxlovid – peroralna terapijska mogućnost u liječenju COVID-19
Paxlovid – oral therapeutic possibility in the treatment of COVID-19

Andrea Vukić Dugac

APEXXNAR- pneumokokno konjugirano cjepivo sljedeće generacije
Apexxnar – pneumococcal conjugate vaccine next generation

17:35-17:55

Tajana Jalušić Glunčić

Plućna rehabilitacija u COVID-19 i post COVID-19 bolesnika
Pulmonary rehabilitation in COVID-19 and post COVID-19 patients

20:00Druženje i domjenak u Johann Francku, Trg bana Josipa Jelačića 9, Zagreb
Get-together evening at the Johann Franck, Trg bana Josipa Jelačića 9, Zagreb
 Subota, 27. svibnja 2023. | Saturday, May 27th 2023
08:30-11:00Registracija sudionika | Registration
 Voditelji | Chairpersons : Zoran Janevski, Tajana Jalušić Glunčić, Ana Hećimović
09:00-10:00TRANSPLANTACIJA PLUĆA | LUNG TRANSPLANTATION
09:00-09:15

Ines Bojanić

Uloga ekstrakorporalne fotofereze u transplantaciji pluća
The role of extracorporeal photopheresis in lung transplantation

09:15-09:30

Fedža Džubur

Indikacije i kontraindikacije za transplantaciju pluća
Indications and contraindications for lung transplantation

09:30-09:45

Goran Madžarac

Evaluacija kvalitete i podudarnosti organa za transplantaciju pluća
Evaluation of the quality and compatibility of donor organ in lung transplantation programme

09:45-10:00

Tomislav Kopjar

Prikaz rezultata programa transplantacije pluća KBC Zagreb
Results of the lung transplantation program at UHC Zagreb

10:00-10:15Simpozij – Sponzoriran
Symposium Sponsored by Pfizer
 

Feđa Džubur

Koliko često pomislimo na gljivične infekcije kod imunokompromitiranih transplantiranih bolesnika
How often do we think of fungal infections in immunocompromised transplant patients

10:15-11:15KOPB i astma blok 
 

Sabina Škrgat

Izazovi u teškoj astmi za kliničare i bolesnike
Challenges in severe asthma for clinicians and patients

 

Branko Pevec

Alergenska imunoterapija – uzročno liječenje alergija
Allergen immunotherapy – disease modifying allergy treatment

 

Sanja Popović-Grle

Novi koncept u opstruktivnim bolestima – dekonstrukcija do “liječivih” svojstava
New concept in obstructive diseases -deconstruction to “Treatable traits”

11:15-11:45

Nagrada za najbolje postere | Best poster award

Gordana Pavliša, Suzana Kukulj, Suzana Mladinov, Ljiljana Bulat Kardum, Željko Čulina, Tanja Zovko, Snježana Benko

en_USEN